Key result
The 2020 Korean guidelines recommend Helicobacter pylori eradication and concomitant proton pump inhibitor use to prevent recurrent peptic ulcers in patients on long-term low-dose aspirin.
Why the study?
Does Helicobacter pylori eradication and concomitant PPI use prevent peptic ulcers in patients with a history of ulcers taking long-term aspirin or antiplatelet agents?
Does Helicobacter pylori eradication and concomitant PPI use prevent peptic ulcers in patients with a history of ulcers taking long-term aspirin or antiplatelet agents?
This review summarizes the 2020 Korean guidelines recommending H. pylori eradication and PPI co-therapy to prevent gastrointestinal complications in high-risk patients requiring long-term antiplatelet therapy.
Guides gastroprotection decisions for long-term aspirin users; leaves open validation in prospective, diverse cohorts.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ji Yong Ahn (2020) conducted a review in Peptic ulcer associated with aspirin and antiplatelet agents. Helicobacter pylori eradication and proton pump inhibitors was evaluated. The 2020 Korean guidelines recommend Helicobacter pylori eradication and concomitant proton pump inhibitor use to prevent recurrent peptic ulcers in patients on long-term low-dose aspirin.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: